PMC:7461420 / 6071-6185 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T35","span":{"begin":56,"end":60},"obj":"Disease"},{"id":"T36","span":{"begin":68,"end":72},"obj":"Disease"}],"attributes":[{"id":"A35","pred":"mondo_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A36","pred":"mondo_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":" CoVs use different human receptors as points of entry: SARS‐CoV‐1, SARS‐CoV‐2, and HCoV‐NL63 use angiotensin‐conv"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T71","span":{"begin":20,"end":25},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":" CoVs use different human receptors as points of entry: SARS‐CoV‐1, SARS‐CoV‐2, and HCoV‐NL63 use angiotensin‐conv"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T24","span":{"begin":98,"end":109},"obj":"Chemical"}],"attributes":[{"id":"A24","pred":"chebi_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"}],"text":" CoVs use different human receptors as points of entry: SARS‐CoV‐1, SARS‐CoV‐2, and HCoV‐NL63 use angiotensin‐conv"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"236","span":{"begin":1,"end":5},"obj":"Species"},{"id":"237","span":{"begin":20,"end":25},"obj":"Species"},{"id":"238","span":{"begin":56,"end":64},"obj":"Species"},{"id":"239","span":{"begin":68,"end":78},"obj":"Species"},{"id":"240","span":{"begin":84,"end":93},"obj":"Species"}],"attributes":[{"id":"A236","pred":"tao:has_database_id","subj":"236","obj":"Tax:11118"},{"id":"A237","pred":"tao:has_database_id","subj":"237","obj":"Tax:9606"},{"id":"A238","pred":"tao:has_database_id","subj":"238","obj":"Tax:694009"},{"id":"A239","pred":"tao:has_database_id","subj":"239","obj":"Tax:2697049"},{"id":"A240","pred":"tao:has_database_id","subj":"240","obj":"Tax:277944"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" CoVs use different human receptors as points of entry: SARS‐CoV‐1, SARS‐CoV‐2, and HCoV‐NL63 use angiotensin‐conv"}